Alexander Mark Schobel

AQST

Alexander Mark Schobel serves as Chief Innovation/Tech Officer at Aquestive Therapeutics, Inc. (AQST). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

1 trades

$44.0K

Total Sells

2 trades

$458.5K

Net Position

Net Seller

$414.4K

Companies Traded

AQST

Active Period

Jun 2022 – Mar 2024

3 total trades

Most Recent

Sell AQST

Mar 15, 2024 · $300.0K

Alexander Mark Schobel's Insider Trading at Aquestive Therapeutics, Inc. (AQST)

Buys

1 · $44.0K

Sells

2 · $458.5K

Total Shares Bought

45,871

Total Shares Sold

80,895

AQST Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value
Mar 15, 2024	Sell	50,000	$6.00	$300.0K
Mar 8, 2024	Sell	30,895	$5.13	$158.5K
Jun 8, 2022	Buy	45,871	$0.96	$44.0K

Related Insiders

Daniel Barber

President and CEO

AQSTSell · May 18, 2026

Peter E. Boyd

See Remarks

AQSTSell · Mar 11, 2026

BRAENDER LORI J

officer: Chief Legal Officer

AQSTSell · Mar 11, 2026

Melina Cioffi

SVP, Regulatory Affairs

AQSTSell · Mar 11, 2026

Cassie Jung

officer: Chief Operating Officer

AQSTSell · Mar 11, 2026

Sherry Korczynski

officer: Chief Commercial Officer

AQSTSell · Mar 11, 2026

TOTH A ERNEST JR

officer: Chief Financial Officer

AQSTSell · Mar 11, 2026

Carl N Kraus

Chief Medical Officer

AQSTSell · Oct 15, 2025

Explore More Insider Trading Data

AQST Insider Trading Activity

View all insider trades at Aquestive Therapeutics, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity